Serpex Medical develops steerable catheters that provide enhanced articulation and access to peripheral lung nodules. These tools enable physicians to navigate complex airway anatomies for improved diagnostic and therapeutic procedures.
Funding
$1.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for accessing and sampling peripheral lung nodules often lack the precision and maneuverability needed to navigate complex airway anatomies, leading to diagnostic uncertainty and potentially requiring more invasive procedures. Traditional bronchoscopes and catheters can be difficult to steer into the far reaches of the lungs, limiting the ability to effectively reach and biopsy small or hard-to-reach nodules.
Solution
Serpex Medical is developing steerable catheters designed to enhance articulation and access to peripheral lung nodules. These tools aim to provide physicians with improved navigation through complex airway anatomies, facilitating more accurate diagnostic and therapeutic procedures. By offering enhanced maneuverability, Serpex Medical's technology seeks to improve the success rate of biopsies and treatments in the peripheral regions of the lung, potentially reducing the need for more invasive surgical interventions.
Target Audience
The primary target audience includes pulmonologists, thoracic surgeons, and interventional radiologists who perform diagnostic and therapeutic procedures in the lungs.
Features
- Enhanced articulation for precise navigation through complex airway anatomies.
- Steerable catheter design for improved access to peripheral lung nodules.